IL6

Open Access
Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
DIAMANTIS I. TSILIMIGRAS, KALLIOPI THANOPOULOU, MARIA SALAGIANNI, GERASIMOS SIASOS, EVANGELOS OIKONOMOU, DESPINA D. PERREA, NIKOLAOS NIRAKIS, KONSTANTINOS FILIS, KONSTANTINOS TSIOUFIS, DIMITRIOS TOUSOULIS and FRAGISKA SIGALA

In Vivo May 2023, 37 (3) 994-1002; DOI: https://doi.org/10.21873/invivo.13173
You have access
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
KAREL SMETANA, DANIEL ROSEL and JAN BRÁBEK

In Vivo September 2020, 34 (5) 3027-3028; DOI: https://doi.org/10.21873/invivo.12135
You have access
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
KAREL SMETANA and JAN BRÁBEK

In Vivo June 2020, 34 (3 suppl) 1589-1592; DOI: https://doi.org/10.21873/invivo.11947
You have access
The Effect of Geraniol on Liver Regeneration After Hepatectomy in Rats
MEDIHA CANBEK, MUSTAFA UYANOGLU, SELCUK CANBEK, EMRE CEYHAN, AHMET OZEN, BASAK DURMUS and OZGE TURGAK

In Vivo March 2017, 31 (2) 209-213;
You have access
IL6 Plasma Concentrations in Patients with Sepsis Receiving SLED and Antibiotics: A Predictor for Survival
TIMOTHY R. MCGUIRE, NICOLE T. REARDON, KIMBERLY BOGARD, TROY J. PLUMB, CHRIS J. BULTSMA, STEVE W. NISSEN, PATRICK D. FULLER and KEITH M. OLSEN

In Vivo November 2014, 28 (6) 1131-1134;

Main menu